SEC Form 4 · accession 0001127602-18-023565
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Davide Molho
Officer — President & COO
Period of report
Jul 17, 2018
Accepted (ET)
Jul 19, 2018 · 8:37 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 17, 2018 | M | 6,165 | $76.67 | A | 44,805 | D | |
| Common StockF2 | Jul 17, 2018 | S | 11,126 | $120.00 | D | 33,679 | D | |
| Common StockF3 | holding | — | — | — | 40,748 | I | By Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $76.67 | Jul 17, 2018 | M | 6,165 | D | Feb 27, 2016 | Feb 27, 2020 | Common Stock | 6,165 | 6,165 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.
- F2On 3/08/2018: 3,514 shares were transferred from Direct Holdings to the Revocable Trust. On 6/05/2018: 21,485 shares were transferred from the Revocable Trust to Direct Holdings.
- F3On 3/08/2018: 3,514 shares were transferred from Direct Holdings to the Revocable Trust. On 6/05/2018: 21,485 shares were transferred from the Revocable Trust to Direct Holdings.